Elective Weight Loss in New York, NY operates under the medical direction of Dr. Sharon Giese, MD, a physician who has dedicated her practice to the intersection of weight management, body composition analysis, and adipose tissue research. The clinic provides medically supervised weight loss programs that incorporate GLP-1 receptor agonist medications—including semaglutide and tirzepatide—as part of comprehensive metabolic treatment plans. Dr. Giese's approach extends beyond simple calorie restriction, addressing the hormonal and physiological mechanisms that regulate appetite, satiety, and fat storage. Patients receive individualized protocols based on metabolic assessments, body composition measurements, and personal health histories rather than one-size-fits-all prescriptions.
The clinic's treatment framework combines pharmacotherapy with structured nutritional guidance and body contouring consultations for patients seeking comprehensive aesthetic outcomes. GLP-1 medications work by mimicking incretin hormones that regulate insulin secretion and slow gastric emptying, creating sustained feelings of fullness that support caloric reduction without constant hunger. Dr. Giese monitors patients for appropriate dosing escalation, manages potential side effects such as nausea or gastrointestinal changes, and adjusts treatment based on weight loss velocity and tolerance. For patients who achieve significant weight reduction, the clinic offers consultations regarding body contouring procedures to address excess skin or localized fat deposits that persist after medical weight loss. This integrated model acknowledges that sustainable weight management often requires both metabolic intervention and attention to physical changes that affect patient confidence and adherence.
Dr. Sharon Giese brings a research-informed perspective to clinical weight management, having studied fat metabolism and the biological factors that contribute to obesity and weight regain. Her medical training emphasizes evidence-based interventions, and she stays current with emerging data on GLP-1 therapies, combination treatments, and long-term maintenance strategies. Patients benefit from a physician who understands not only the prescribing guidelines for these medications but also the underlying science of adipocyte function, inflammatory markers in obesity, and the neuroendocrine feedback loops that complicate weight loss efforts. This depth of knowledge allows Dr. Giese to explain treatment rationales clearly, set realistic expectations, and troubleshoot challenges that arise during the weight loss process.
Patients at Elective Weight Loss in New York can expect initial consultations that include detailed medical histories, discussion of previous weight loss attempts, review of comorbid conditions such as type 2 diabetes or hypertension, and establishment of measurable goals. The clinic offers hybrid care, meaning patients have the option of in-person visits at the New York location or telehealth appointments for ongoing management and medication adjustments. Telehealth services are available to patients throughout New York State, providing access to Dr. Giese's expertise without the need for repeated travel into the city. Follow-up visits typically occur monthly during active weight loss phases, with frequency adjusted based on individual progress and medication titration schedules. Patients receive guidance on managing common side effects, optimizing protein intake to preserve lean muscle mass, and incorporating physical activity in ways that support rather than undermine metabolic goals.
What distinguishes Elective Weight Loss from general weight management programs is the clinic's focus on the scientific underpinnings of obesity treatment and Dr. Giese's specific interest in fat research and body composition outcomes. Rather than simply prescribing trending medications, the practice emphasizes patient education about how these therapies work, what realistic timelines look like, and how to transition from active weight loss to maintenance phases. The availability of both telehealth and in-person options in New York, NY makes the clinic accessible to patients across the state who want physician-supervised GLP-1 therapy without sacrificing the convenience of remote care. For individuals who have struggled with weight regain after previous attempts or who want a medically rigorous approach that addresses both the biological and practical aspects of weight management, Dr. Giese's practice offers a structured, science-based pathway.
Dr. Sharon Giese· MD
Dr. Sharon Giese, MD
Board-Certified Plastic Surgeon
Dr. Sharon Giese, MD, a board-certified plastic surgeon, body contour expert, and fat researcher offers her Elective Weight Loss (EWL™) program via in person or virtual consultation nationwide. Dr. Giese started doing fat research over 20 years ago while at Stanford and Georgetown University and collaborated with the National Institutes of Health (NIH) to show large volume liposuction results in weight loss with health benefits.
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.
